Case number 2017-1153
Grunenthal GmbH v. Alkem Laboratories Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | GRUNENTHAL GMBH v. ALKEM LABORATORIES LIMITED [OPINION - PRECEDENTIAL] [precedential] (0) |
| Jun 7, 2019 | 159 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [612405] [17-1153, 17-2048, 17-2049, 17-2050] [JAB] [Entered: 06/07/2019 01:15 PM] (2) |
| May 31, 2019 | 158 | ORDER filed denying [156] petition for panel rehearing, petition for en banc rehearing filed by Alkem Laboratories Limited. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [610710] [JAB] [Entered: 05/31/2019 12:12 PM] (2) |
| Apr 30, 2019 | 157 | 18 paper copies of the petition for panel rehearing [156], petition for en banc rehearing [156] received from Appellant Alkem Laboratories Limited. [604128] [PBC] [Entered: 04/30/2019 03:20 PM] (0) |
| Apr 29, 2019 | 156 | Petition for panel rehearing, for en banc rehearing filed by Appellant Alkem Laboratories Limited. Service: 04/29/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 05/01/2019 [603784] [17-1153] [Ahmed Riaz] [Entered: 04/29/2019 04:47 PM] (48) |
| Mar 28, 2019 | 154 | OPINION filed for the court by Reyna, Circuit Judge; Taranto, Circuit Judge and Chen, Circuit Judge. Precedential Opinion. [596111] [17-1153, 17-2048, 17-2049, 17-2050] [PBC] [Entered: 03/28/2019 09:54 AM] (23) |
| Mar 28, 2019 | 155 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [596113] [17-1153, 17-2048, 17-2049, 17-2050] [PBC] [Entered: 03/28/2019 09:56 AM] (2) |
| Feb 26, 2019 | 153 | Certificate of Interest for the Appellant Hikma Pharmaceuticals International Limited. Service: 02/26/2019 by email. [588801] [17-1153] [Kenneth Schuler] [Entered: 02/26/2019 02:56 PM] (3) |
| Feb 25, 2019 | 152 | ORDER filed granting motion to modify the official caption [151] filed by Appellant West-Ward Pharmaceuticals International Limited in 17-1153. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [588429] [17-1153, 17-2048, 17-2049, 17-2050] [PBC] [Entered: 02/25/2019 03:24 PM] (2) |
| Feb 21, 2019 | 151 | MOTION of Appellant West-Ward Pharmaceuticals International Limited to modify the official caption [Consent: unopposed]. Service: 02/21/2019 by email. [587752] [17-1153] [Kenneth Schuler] [Entered: 02/21/2019 03:56 PM] (9) |
| Sep 6, 2018 | 149 | ORDER filed granting motion to modify the official caption [148] filed by Cross-Appellant Depomed, Inc. in 17-1153. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [547557] [17-1153, 17-2048, 17-2049, 17-2050] [SJ] [Entered: 09/06/2018 08:54 AM] (2) |
| Sep 6, 2018 | 150 | Amended Certificate of Interest for the Cross-Appellant Assertio Therapeutics, Inc.. Service: 09/06/2018 by email. [547655] [17-1153] [Jaysen Chung] [Entered: 09/06/2018 12:22 PM] (2) |
| Sep 5, 2018 | 148 | MOTION of Cross-Appellant Depomed, Inc. to modify the official caption [Consent: unopposed]. Service: 09/05/2018 by email. [547274] [17-1153] [Jaysen Chung] [Entered: 09/05/2018 11:24 AM] (12) |
| Sep 4, 2018 | 147 | Submitted after ORAL ARGUMENT by Imron T. Aly for Alkem Laboratories Limited, Robert J. Gajarsa for West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc., Michael E. Joffre for Actavis Elizabeth LLC and Mr. Michael Sitzman for Depomed, Inc. and Grunenthal GmbH. Panel: Judge: Reyna , Judge: Taranto , Judge: Chen. [546924] [JCP] [Entered: 09/04/2018 01:28 PM] (0) |
| Aug 15, 2018 | 143 | Response to oral argument order from the Appellants West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Designating Robert J. Gajarsa to argue.. Designating 6 minutes for argument. Reserving 3 minutes for rebuttal. [17-1153] [Robert Gajarsa] [Entered: 08/15/2018 02:02 PM] (0) |
| Aug 15, 2018 | 144 | Response to oral argument order from the Appellee Actavis Elizabeth LLC. Designating Michael E. Joffre to argue.. Designating 5 minutes for argument. [17-1153] [Michael Joffre] [Entered: 08/15/2018 02:53 PM] (0) |
| Aug 15, 2018 | 145 | Response to oral argument order from the Appellant Alkem Laboratories Limited. Designating Imron T. Aly to argue.. Designating 5 minutes for argument. Reserving 1 minutes for rebuttal. [17-1153] [Ahmed Riaz] [Entered: 08/15/2018 03:14 PM] (0) |
| Aug 15, 2018 | 146 | Response to oral argument order from the Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Designating Michael A. Sitzman to argue.. Designating 15 minutes for argument. Reserving 5 minutes for rebuttal. [17-1153] [Jaysen Chung] [Entered: 08/15/2018 03:47 PM] (0) |
| Aug 14, 2018 | 142 | ORDER filed. The motion [141] is granted, in that Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals International Limited, and Hikma Pharmaceuticals USA Inc., and appellee Actavis Elizabeth LLC will share 20 minutes of argument time. Cross-appellants Grunenthal GmbH and Depomed, Inc. will also share 20 minutes. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [542643] [JAB] [Entered: 08/14/2018 10:00 AM] (2) |
| Aug 9, 2018 | 141 | MOTION of Appellants Hikma Pharmaceuticals USA Inc., West-Ward Pharmaceuticals International Limited, Alkem Laboratories Limited and Appellee Actavis Elizabeth LLC to Enlarge Time for and Clarify Division of Oral Argument [Consent: opposed]. Service: 08/09/2018 by email. [541830] [17-1153] [Kenneth Schuler] [Entered: 08/09/2018 03:25 PM] (15) |
| Jul 20, 2018 | 140 | NOTICE OF CALENDARING. Panel: 1809A. Case scheduled Sep 04, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to oral argument order due: 08/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [537243] [JAB] [Entered: 07/20/2018 11:46 AM] (0) |
| Jul 19, 2018 | 139 | Amended Certificate of Interest for the Appellant Hikma Pharmaceuticals USA Inc.. Service: 07/19/2018 by email. [536997] [17-1153] [Kenneth Schuler] [Entered: 07/19/2018 12:33 PM] (3) |
| Jul 18, 2018 | 138 | ORDER filed. The motion [137] is granted. The revised official caption is reflected in the order. Service: 07/18/2018 by clerk. [536881] [NL] [Entered: 07/18/2018 04:49 PM] (2) |
| Jul 17, 2018 | 137 | MOTION of Appellant West-Ward Pharmaceuticals Corp. to modify the official caption [Consent: unopposed]. Service: 07/17/2018 by email. [536487] [17-1153] --[Edited 07/17/2018 by CAB to correct party filer] [Kenneth Schuler] [Entered: 07/17/2018 12:26 PM] (10) |
| Jul 9, 2018 | 136 | 6 paper copies of the Corrected Confidential Joint Appendix Brief (Vol. I - VII) [134] received from Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. [534428] [CJF] [Entered: 07/09/2018 01:40 PM] (0) |
| Jun 28, 2018 | 130 | Notice of Correction to the appendix Brief Doc No. [119], appendix Brief Doc No. [118] for Appellants West-Ward Pharmaceuticals International Limited and West-Ward Pharmaceuticals Corp.. Service: 06/28/2018 by email. [532512] [17-1153] [Kenneth Schuler] [Entered: 06/28/2018 12:00 PM] (4) |
| Jun 28, 2018 | 131 | TENDERED from Appellants West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Alkem Laboratories Limited, Appellee Actavis Elizabeth LLC and Cross-Appellants Grunenthal GmbH and Depomed, Inc.. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 06/28/2018 by email. [532522] [17-1153] [Kenneth Schuler] [Entered: 06/28/2018 12:16 PM] (0) |
| Jun 28, 2018 | 132 | TENDERED from Appellants West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Alkem Laboratories Limited, Appellee Actavis Elizabeth LLC and Cross-Appellants Grunenthal GmbH and Depomed, Inc.. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 06/28/2018 by email. [532526] [17-1153] [Kenneth Schuler] [Entered: 06/28/2018 12:26 PM] (0) |
| Jun 28, 2018 | 133 | TENDERED from Appellants West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Alkem Laboratories Limited, Appellee Actavis Elizabeth LLC and Cross-Appellants Grunenthal GmbH and Depomed, Inc.. Title: CORRECTED JOINT APPENDIX. Service: 06/28/2018 by email. [532529] [17-1153] [Kenneth Schuler] [Entered: 06/28/2018 12:37 PM] (2929) |
| Jun 28, 2018 | 134 | CORRECTED CONFIDENTIAL JOINT APPENDIX, VOLS. I - VII FILED for Appellants West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Alkem Laboratories Limited, Appellee Actavis Elizabeth LLC, and Cross-Appellants Grunenthal GmbH and Depomed, Inc. [131], [132]. Number of Pages: 3,848. Service: 06/28/2018 by email. The paper copies of the brief should be received by the court on or before 07/12/2018. [533659] [CAB] [Entered: 07/05/2018 09:49 AM] (0) |
| Jun 28, 2018 | 135 | CORRECTED JOINT APPENDIX, VOLS. I - VII FILED for for Appellants West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Alkem Laboratories Limited, Appellee Actavis Elizabeth LLC, and Cross-Appellants Grunenthal GmbH and Depomed, Inc. [133]. Number of Pages: 2,929. Service: 06/28/2018 by email. [533667] [CAB] [Entered: 07/05/2018 10:14 AM] (2929) |
| Apr 12, 2018 | 129 | **TEXT ONLY** ORDER granting motion to withdraw Terrence J. Connolly as counsel [128] filed by Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [512733] [CAB] [Entered: 04/12/2018 08:55 AM] (0) |
| Apr 11, 2018 | 128 | MOTION of Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited to withdraw counsel Terrence J. Connolly. Any response is due within 10 days of service. [Consent: unopposed]. Service: 04/11/2018 by email. [512619] [17-1153] [Kenneth Schuler] [Entered: 04/11/2018 04:32 PM] (10) |
| Apr 3, 2018 | 125 | NOTICE OF DEFICIENCY: The party letter Document No. [122] filed by Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited in 17-1153 is submitted using the incorrect event and therefore cannot be accepted for filing at this time (Document must be submitted under the "Notice Regarding Conflicts with Argument Dates" event). You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [510197] [JAB] [Entered: 04/03/2018 12:39 PM] (0) |
| Apr 3, 2018 | 126 | Notice from Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited regarding conflicts with oral argument (August 6-10). Service: 04/03/2018 by email. [510224] [17-1153] [Robert Gajarsa] [Entered: 04/03/2018 01:37 PM] (1) |
| Apr 3, 2018 | 127 | Notice from Appellee Actavis Elizabeth LLC regarding conflicts with oral argument (June 8 and July 9-13, 2018). Service: 04/03/2018 by email. [510319] [17-1153] [Michael Joffre] [Entered: 04/03/2018 03:13 PM] (1) |
| Apr 2, 2018 | 122 | Letter from Appellants West-Ward Pharmaceuticals International Limited and West-Ward Pharmaceuticals Corp. regarding conflicts with oral argument. Service: 04/02/2018 by email. [509835] [17-1153] [Robert Gajarsa] [Entered: 04/02/2018 01:48 PM] (0) |
| Apr 2, 2018 | 123 | 6 paper copies of the Confidential Joint Appendix in 7 Volumes [118] received for Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Appellee Actavis Elizabeth LLC and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. [509871] [SJL] [Entered: 04/02/2018 02:31 PM] (0) |
| Apr 2, 2018 | 124 | Notice from Cross-Appellant Depomed, Inc. regarding conflicts with oral argument (April 8-9, 2018 and June 7-8, 2018). Service: 04/02/2018 by email. [509925] [17-1153] [Michael Sitzman] [Entered: 04/02/2018 03:36 PM] (1) |
| Mar 30, 2018 | 121 | Notice from Appellant Alkem Laboratories Limited regarding conflicts with oral argument (April 6; May 3-4; July 9-13). Service: 03/30/2018 by email. [509584] [17-1153] [Ahmed Riaz] [Entered: 03/30/2018 01:48 PM] (3) |
| Mar 27, 2018 | 120 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/03/2018. [508184] [CAB] [Entered: 03/27/2018 11:03 AM] (0) |
| Mar 26, 2018 | 107 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Actavis Elizabeth LLC, Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Service: 03/26/2018 by email. [507958] [17-1153] [Ahmed Riaz] [Entered: 03/26/2018 03:24 PM] (4) |
| Mar 26, 2018 | 108 | TENDERED from Appellee Actavis Elizabeth LLC, Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Title: JOINT APPENDIX. Service: 03/26/2018 by email. [507964] [17-1153] This brief has been corrected. See Doc No. [135] [Ahmed Riaz] [Entered: 03/26/2018 03:33 PM] (0) |
| Mar 26, 2018 | 109 | TENDERED from Appellee Actavis Elizabeth LLC, Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Title: JOINT APPENDIX. Service: 03/26/2018 by email. [507968] [17-1153] This brief has been corrected. See Doc No. [135] [Ahmed Riaz] [Entered: 03/26/2018 03:39 PM] (0) |
| Mar 26, 2018 | 110 | TENDERED from Appellee Actavis Elizabeth LLC, Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Title: CONFIDENTIAL JOINT APPENDIX Service: 03/26/2018 by email. [507974] [17-1153] This brief has been corrected. See Doc No. [134] [Ahmed Riaz] [Entered: 03/26/2018 03:48 PM] (0) |
| Mar 26, 2018 | 111 | TENDERED from Appellee Actavis Elizabeth LLC, Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Title: CONFIDENTIAL JOINT APPENDIX Service: 03/26/2018 by email. [507981] [17-1153] This brief has been corrected. See Doc No. [134] [Ahmed Riaz] [Entered: 03/26/2018 03:54 PM] (0) |
| Mar 26, 2018 | 112 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Actavis Elizabeth LLC, Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Service: 03/26/2018 by email. [507990] [17-1153] [Ahmed Riaz] [Entered: 03/26/2018 04:03 PM] (4) |
| Mar 26, 2018 | 113 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellant Grunenthal GmbH. Service: 03/26/2018 by email. [507999] [17-1153] [Linda Wadler] [Entered: 03/26/2018 04:14 PM] (3) |
| Mar 26, 2018 | 114 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants West-Ward Pharmaceuticals International Limited and West-Ward Pharmaceuticals Corp.. Service: 03/26/2018 by email. [508003] [17-1153] [Kenneth Schuler] [Entered: 03/26/2018 04:19 PM] (3) |
| Mar 26, 2018 | 115 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellant Depomed, Inc.. Service: 03/26/2018 by email. [508018] [17-1153] [Jaysen Chung] [Entered: 03/26/2018 04:41 PM] (3) |
| Mar 26, 2018 | 116 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Actavis Elizabeth LLC. Service: 03/26/2018 by email. [508025] [17-1153] [Michael Joffre] [Entered: 03/26/2018 05:09 PM] (4) |
| Mar 26, 2018 | 117 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Alkem Laboratories Limited. Service: 03/26/2018 by email. [508055] [17-1153] [Ahmed Riaz] [Entered: 03/26/2018 08:12 PM] (5) |
| Mar 26, 2018 | 118 | CONFIDENTIAL JOINT APPENDIX, VOLS. I - VII FILED for Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Actavis Elizabeth LLC, Depomed, Inc., and Grunenthal GmbH [110], [111]. Number of Pages: 3,836. Service: 03/26/2018 by email, US mail. The paper copies of the brief should be received by the court on or before 04/03/2018. [508145] This brief has been corrected. See Doc No. [134] [CAB] [Entered: 03/27/2018 09:58 AM] (0) |
| Mar 26, 2018 | 119 | JOINT APPENDIX, VOLS. I - VII FILED for Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Actavis Elizabeth LLC, Depomed, Inc., and Grunenthal GmbH [108], [109]. Number of Pages: 2,822. Service: 03/26/2018 by email. [508162] This brief has been corrected. See Doc No. [135] [CAB] [Entered: 03/27/2018 10:36 AM] (0) |
| Mar 19, 2018 | 105 | MOTION of Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited to extend the time to 03/26/2018 to file the appendix. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/16/2018 by email. [505851] [Imron Aly] [Entered: 03/16/2018 10:54 AM] (10) |
| Mar 19, 2018 | 106 | **TEXT ONLY** ORDER granting motion to extend time to file appendix [105] filed by Appellants West-Ward Pharmaceuticals Corp., Alkem Laboratories Limited, and West-Ward Pharmaceuticals International Limited. Appendix due 03/26/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [505911] [CAB] [Entered: 03/16/2018 11:36 AM] (0) |
| Mar 13, 2018 | 104 | 6 paper copies of the Reply Brief [102] received from Cross-Appellant Depomed, Inc. [504711] [JCP] [Entered: 03/13/2018 03:40 PM] (0) |
| Mar 7, 2018 | 100 | TENDERED from Cross-Appellant Depomed, Inc.. Title: REPLY BRIEF. Service: 03/07/2018 by email. [503300] [Michael Sitzman] [Entered: 03/07/2018 03:37 PM] (39) |
| Mar 7, 2018 | 101 | TENDERED from Cross-Appellant Grunenthal GmbH. Title: NOTICE OF JOINDER. Service: 03/07/2018 by email. [503319] [Linda Wadler] [Entered: 03/07/2018 03:58 PM] (5) |
| Mar 7, 2018 | 102 | REPLY BRIEF FILED for Cross-Appellant Depomed, Inc. [100]. Number of Pages: 30. Service: 03/07/2018 by email. The paper copies of the brief should be received by the court on or before 03/15/2018. Appendix is due 03/19/2018. [503620]--[Edited 03/08/2018 by CAB to correct filing date.] [CAB] [Entered: 03/08/2018 03:52 PM] (39) |
| Mar 7, 2018 | 103 | Notice of Joinder for Cross-Appellant Grunenthal GmbH [101] joining in [102] Reply Brief submitted by Cross-Appellant Depomed, Inc. in 17-1153. Service: 03/07/2018 by email. [503624] [CAB] [Entered: 03/08/2018 03:56 PM] (5) |
| Feb 12, 2018 | 99 | 6 paper copies of the Reply Brief [94] received from Appellant Alkem Laboratories Limited. [496984] [SJL] [Entered: 02/12/2018 10:44 AM] (0) |
| Feb 6, 2018 | 97 | 6 paper copies of the Opening Response Brief [95] received from Appellee Actavis Elizabeth LLC. [495776] [JCP] [Entered: 02/07/2018 09:04 AM] (0) |
| Feb 5, 2018 | 98 | 6 paper copies of the Reply Brief [96] received from Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. [495800] [JCP] [Entered: 02/07/2018 09:41 AM] (0) |
| Jan 31, 2018 | 91 | TENDERED from Appellant Alkem Laboratories Limited. Title: REPLY BRIEF. Service: 01/31/2018 by email. [494197] [Imron Aly] [Entered: 01/31/2018 05:12 PM] (51) |
| Jan 31, 2018 | 92 | TENDERED from Appellee Actavis Elizabeth LLC. Title: RESPONSE BRIEF. Service: 01/31/2018 by email. [494199] [Michael Joffre] [Entered: 01/31/2018 05:35 PM] (47) |
| Jan 31, 2018 | 93 | TENDERED from Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. Title: REPLY BRIEF. Service: 01/31/2018 by email. [494214] [Kenneth Schuler] [Entered: 01/31/2018 06:31 PM] (80) |
| Jan 31, 2018 | 94 | REPLY BRIEF FILED for Appellant Alkem Laboratories Limited [91]. Number of Pages: 40. Service: 01/31/2018 by email. The paper copies of the brief should be received by the court on or before 02/12/2018. [495043] [CAB] [Entered: 02/05/2018 10:38 AM] (51) |
| Jan 31, 2018 | 95 | BRIEF FILED for Appellee Actavis Elizabeth LLC [92]. Number of Pages: 38. Service: 01/31/2018 by email. The paper copies of the brief should be received by the court on or before 02/12/2018. [495044] [CAB] [Entered: 02/05/2018 10:40 AM] (47) |
| Jan 31, 2018 | 96 | REPLY BRIEF FILED for Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited [93]. Number of Pages: 63. Service: 01/31/2018 by email. The paper copies of the brief should be received by the court on or before 02/12/2018. [495045] [CAB] [Entered: 02/05/2018 10:42 AM] (80) |
| Dec 28, 2017 | 90 | ORDER granting motion to withdraw attorney Basil J. Lewris [87] filed by Cross-Appellant Grunenthal GmbH. Service as of this date by Clerk of Court. [486100] [CMP] [Entered: 12/28/2017 02:56 PM] (2) |
| Dec 20, 2017 | 86 | ORDER filed. The motion [85] is granted. Service: 12/20/2017 by clerk. [484237] [NL] [Entered: 12/20/2017 01:13 PM] (2) |
| Dec 20, 2017 | 87 | MOTION of Cross-Appellant Grunenthal GmbH to withdraw counsel Basil J. Lewris. Any response is due within 10 days of service [Consent: not addressed]. Service: 12/20/2017 by email. [484304] [Linda Wadler] [Entered: 12/20/2017 02:11 PM] (5) |
| Dec 20, 2017 | 88 | Amended Entry of appearance for Linda A. Wadler as principal counsel for Cross-Appellant Grunenthal GmbH. Service: 12/20/2017 by email. [484307] [Linda Wadler] [Entered: 12/20/2017 02:12 PM] (2) |
| Dec 20, 2017 | 89 | Amended Certificate of Interest for the Cross-Appellant Grunenthal GmbH. Service: 12/20/2017 by email. [484310] [Linda Wadler] [Entered: 12/20/2017 02:13 PM] (3) |
| Dec 13, 2017 | 85 | MOTION of Appellants Alkem Laboratories Limited, West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited, Appellee Actavis Elizabeth LLC and Cross-Appellants Depomed, Inc. and Grunenthal GmbH to extend the time to 01/31/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service, to extend the time to 03/07/2018 to file the cross-appellant's reply brief. Any response is due within 10 days of service, to extend the time to 01/31/2018 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/13/2017 by email. [482264] [John Rozendaal] [Entered: 12/13/2017 09:40 AM] (29) |
| Dec 8, 2017 | 84 | 6 paper copies of the Opening Response Brief [81] received from Cross-Appellant Depomed, Inc.. [481898] [CAB] [Entered: 12/12/2017 09:43 AM] (0) |
| Dec 7, 2017 | 83 | 6 paper copies of the Opening Response Brief [82] received from Cross-Appellant Grunenthal GmbH. [481057] [CAB] [Entered: 12/07/2017 05:12 PM] (0) |
| Dec 1, 2017 | 77 | TENDERED from Cross-Appellant Depomed, Inc.. Title: RESPONSE BRIEF. Service: 12/01/2017 by email. [479757] [Michael Sitzman] [Entered: 12/01/2017 06:19 PM] (91) |
| Dec 1, 2017 | 78 | TENDERED from Cross-Appellant Grunenthal GmbH. Title: RESPONSE BRIEF. Service: 12/01/2017 by email. [479762] [Basil Lewris] [Entered: 12/01/2017 08:14 PM] (71) |
| Dec 1, 2017 | 79 | Amended Certificate of Interest for the Cross-Appellant Grunenthal GmbH. Service: 12/01/2017 by email. [479763] [Basil Lewris] [Entered: 12/01/2017 08:15 PM] (3) |
| Dec 1, 2017 | 80 | Amended Certificate of Interest for the Cross-Appellant Depomed, Inc.. Service: 12/01/2017 by email. [479766] [Michael Sitzman] [Entered: 12/01/2017 08:49 PM] (2) |
| Dec 1, 2017 | 81 | BRIEF FILED for Cross-Appellant Depomed, Inc. [77]. Number of Pages: 77. Service: 12/01/2017 by email. The paper copies of the brief should be received by the court on or before 12/13/2017. Appellee Actavis Elizabeth LLC's brief is due 01/10/2018. [480647] [CAB] [Entered: 12/06/2017 02:17 PM] (91) |
| Dec 1, 2017 | 82 | BRIEF FILED for Cross-Appellant Grunenthal GmbH [78]. Number of Pages: 61. Service: 12/01/2017 by email. The paper copies of the brief should be received by the court on or before 12/13/2017. Appellee Actavis Elizabeth LLC's brief is due 01/10/2018. [480652] [CAB] [Entered: 12/06/2017 02:21 PM] (71) |
| Oct 5, 2017 | 76 | ORDER filed. The motion [73] is granted. The revised official caption is reflected in the order. Service: 10/05/2017 by clerk. [465946] [LMS] [Entered: 10/05/2017 04:10 PM] (2) |
| Oct 3, 2017 | 73 | MOTION of Appellee Actavis Elizabeth LLC to modify the official caption. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/03/2017 by email. [465284] [Michael Joffre] [Entered: 10/03/2017 03:59 PM] (10) |
| Oct 3, 2017 | 74 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellee's motion [73] included a revised Certificate of Interest (COI). CORRECTION: When information included on the COI changes, an amended COI must be filed pursuant to FCR 47.4(c). Please file an amended COI promptly. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [465297] [MJL] [Entered: 10/03/2017 04:07 PM] (0) |
| Oct 3, 2017 | 75 | Amended Certificate of Interest for the Appellee Actavis Elizabeth LLC and Not party Actavis Laboratories UT, Inc.. Service: 10/03/2017 by email. [465339] [Michael Joffre] [Entered: 10/03/2017 07:07 PM] (3) |
| Sep 12, 2017 | 71 | 6 paper copies of the Opening Brief [70] received from Appellant Alkem Laboratories Limited. [460377] [CW] [Entered: 09/12/2017 12:07 PM] (0) |
| Sep 12, 2017 | 72 | 6 paper copies of the Opening Brief [69] received from Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. [460382] [CW] [Entered: 09/12/2017 12:12 PM] (0) |
| Sep 7, 2017 | 67 | TENDERED from Appellant Alkem Laboratories Limited. Title: OPENING BRIEF. Service: 09/07/2017 by email. [459541] [Imron Aly] [Entered: 09/07/2017 06:15 PM] (325) |
| Sep 7, 2017 | 68 | TENDERED from Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. Title: OPENING BRIEF. Service: 09/07/2017 by email. [459547] [Kenneth Schuler] [Entered: 09/07/2017 10:44 PM] (333) |
| Sep 7, 2017 | 69 | BRIEF FILED for Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited [68]. Number of Pages: 68. Service: 09/07/2017 by email. The paper copies of the brief should be received by the court on or before 09/18/2017. Cross-Appellants’ principal brief is due on 12/01/2017. [460040] [CAB] [Entered: 09/11/2017 10:55 AM] (333) |
| Sep 7, 2017 | 70 | BRIEF FILED for Appellant Alkem Laboratories Limited [67]. Number of Pages: 44. Service: 09/07/2017 by email. The paper copies of the brief should be received by the court on or before 09/18/2017. Cross-Appellants’ principal brief is due on 12/01/2017. [460054] [CAB] [Entered: 09/11/2017 11:13 AM] (325) |
| Aug 1, 2017 | 66 | ORDER filed. The motion [65] is granted. The revised official caption is reflected in the order. Service: 08/01/2017 by clerk. [450581] [LMS] [Entered: 08/01/2017 10:09 AM] (2) |
| Jul 27, 2017 | 65 | MOTION of Appellant Roxane Laboratories, Inc. to substitute party. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/27/2017 by email. [449737] [Kenneth Schuler] [Entered: 07/27/2017 02:00 PM] (11) |
| Jun 22, 2017 | 63 | Notice of intent to file corresponding briefs on CD-ROM for Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Service: 06/22/2017 by email. [441386] [Michael Sitzman] [Entered: 06/22/2017 12:53 PM] (3) |
| Jun 22, 2017 | 64 | Notice of intent to file corresponding briefs on CD-ROM for Appellant Alkem Laboratories Limited. Service: 06/22/2017 by email. [441436] [Ahmed Riaz] [Entered: 06/22/2017 02:33 PM] (3) |
| Jun 14, 2017 | 62 | ORDER filed. The motion [60] is granted to the extent that the revised official caption is reflected in the order. Service: 06/14/2017 by clerk. [439191] [LMS] [Entered: 06/14/2017 12:38 PM] (2) |
| Jun 12, 2017 | 61 | ORDER granting motion to extend time to file appellants’ principal brief [59] and granting motion to extend time to file cross-appellants’ principal brief [59] filed by Appellants Roxane Laboratories, Inc. and Alkem Laboratories Limited, and Cross-Appellants Depomed, Inc. and Grunenthal GmbH. Appellants’ brief is due 09/07/2017. Cross-Appellants’ brief due 12/01/2017. Service as of this date by Clerk of Court. [438269] [CAB] [Entered: 06/12/2017 10:30 AM] (2) |
| Jun 9, 2017 | 60 | MOTION of Appellee Actavis Elizabeth LLC to modify the official caption. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/09/2017 by email. [438107] [Michael Joffre] [Entered: 06/09/2017 05:12 PM] (5) |
| Jun 8, 2017 | 58 | MOTION of Appellants Alkem Laboratories Limited, Roxane Laboratories, Inc. and Cross-Appellants Depomed, Inc. and Grunenthal GmbH to extend the time to 09/07/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to extend the time to 10/17/2017 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/08/2017 by email. [437458] [Kenneth Schuler] [Entered: 06/08/2017 11:12 AM] (21) |
| Jun 8, 2017 | 59 | MOTION of Appellants Alkem Laboratories Limited, Roxane Laboratories, Inc. and Cross-Appellants Depomed, Inc. and Grunenthal GmbH to extend the time to 09/07/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to extend the time to 12/01/2017 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/08/2017 by email. [437535] [Kenneth Schuler] [Entered: 06/08/2017 12:48 PM] (21) |
| Jun 5, 2017 | 57 | Amended Docketing Statement for the Cross-Appellant Grunenthal GmbH. Service: 06/05/2017 by email. [436413] [Basil Lewris] [Entered: 06/05/2017 03:40 PM] (5) |
| Jun 2, 2017 | 56 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance for Attorney William H. Milliken, Docket No. [49], ERROR: The contact information on Attorney William H. Milliken's entry of appearance does not match the information on Mr. Milliken's ECF filer account. CORRECTION: ECF account information may be updated at www.pacer.gov, or counsel may file amended EOA reflecting the correct information. [435934] [CAB] [Entered: 06/02/2017 11:49 AM] (0) |
| Jun 1, 2017 | 34 | Amended Docketing Statement for the Cross-Appellant Grunenthal GmbH. Service: 06/01/2017 by email. [435607] [Basil Lewris] [Entered: 06/01/2017 11:27 AM] (5) |
| Jun 1, 2017 | 35 | Amended Certificate of Interest for the Cross-Appellant Depomed, Inc.. Service: 06/01/2017 by email. [435632] [Michael Sitzman] [Entered: 06/01/2017 12:12 PM] (2) |
| Jun 1, 2017 | 36 | Amended Entry of appearance for Michael A. Sitzman as principal counsel for Cross-Appellant Depomed, Inc.. Service: 06/01/2017 by email. [435633] [Michael Sitzman] [Entered: 06/01/2017 12:15 PM] (3) |
| Jun 1, 2017 | 37 | Amended Entry of appearance for Timothy P. Best as of counsel for Cross-Appellant Depomed, Inc.. Service: 06/01/2017 by email. [435634] [Michael Sitzman] [Entered: 06/01/2017 12:18 PM] (3) |
| Jun 1, 2017 | 38 | Amended Entry of appearance for Jaysen S. Chung as of counsel for Cross-Appellant Depomed, Inc.. Service: 06/01/2017 by email. [435635] [Michael Sitzman] [Entered: 06/01/2017 12:20 PM] (3) |
| Jun 1, 2017 | 39 | Amended Entry of appearance for Christine L. Ranney as of counsel for Cross-Appellant Depomed, Inc.. Service: 06/01/2017 by email. [435637] [Michael Sitzman] [Entered: 06/01/2017 12:23 PM] (3) |
| Jun 1, 2017 | 40 | Amended Docketing Statement for the Cross-Appellant Depomed, Inc.. Service: 06/01/2017 by email. [435638] [Michael Sitzman] [Entered: 06/01/2017 12:24 PM] (5) |
| Jun 1, 2017 | 41 | Docketing Statement for the Appellant Alkem Laboratories Limited. Service: 06/01/2017 by email. [435723] [Jason Harp] [Entered: 06/01/2017 03:47 PM] (3) |
| Jun 1, 2017 | 42 | Entry of appearance for Kenneth G. Schuler as principal counsel for Appellant Roxane Laboratories, Inc.. Service: 06/01/2017 by email. [435732] [Kenneth Schuler] [Entered: 06/01/2017 03:57 PM] (3) |
| Jun 1, 2017 | 43 | Certificate of Interest for the Appellant Roxane Laboratories, Inc.. Service: 06/01/2017 by email. [435736] [Kenneth Schuler] [Entered: 06/01/2017 04:00 PM] (3) |
| Jun 1, 2017 | 44 | Docketing Statement for the Appellant Roxane Laboratories, Inc.. Service: 06/01/2017 by email. [435738] [Kenneth Schuler] [Entered: 06/01/2017 04:02 PM] (5) |
| Jun 1, 2017 | 45 | Entry of appearance for Terrence J. Connolly as of counsel for Appellant Roxane Laboratories, Inc.. Service: 06/01/2017 by email. [435744] [Terrence Connolly] [Entered: 06/01/2017 04:06 PM] (3) |
| Jun 1, 2017 | 46 | Entry of appearance for Robert J. Gajarsa as of counsel for Appellant Roxane Laboratories, Inc.. Service: 06/01/2017 by email. [435748] [Robert Gajarsa] [Entered: 06/01/2017 04:11 PM] (3) |
| Jun 1, 2017 | 47 | Entry of appearance for Gregory K. Sobolski as of counsel for Appellant Roxane Laboratories, Inc.. Service: 06/01/2017 by email. [435752] [Gregory Sobolski] [Entered: 06/01/2017 04:14 PM] (3) |
| Jun 1, 2017 | 48 | Entry of appearance for Michael E. Joffre as principal counsel for Appellees Actavis Elizabeth LLC and Actavis Laboratories UT, Inc.. Service: 06/01/2017 by email. [435788] [Michael Joffre] [Entered: 06/01/2017 05:41 PM] (2) |
| Jun 1, 2017 | 49 | Entry of appearance for William H. Milliken as of counsel for Appellees Actavis Elizabeth LLC and Actavis Laboratories UT, Inc.. Service: 06/01/2017 by email. [435789] [William Milliken] [Entered: 06/01/2017 05:46 PM] (2) |
| Jun 1, 2017 | 50 | Certificate of Interest for the Appellees Actavis Elizabeth LLC and Actavis Laboratories UT, Inc.. Service: 06/01/2017 by email. [435790] [Michael Joffre] [Entered: 06/01/2017 05:50 PM] (2) |
| Jun 1, 2017 | 51 | Docketing Statement for the Appellees Actavis Elizabeth LLC and Actavis Laboratories UT, Inc.. Service: 06/01/2017 by email. [435791] [Michael Joffre] [Entered: 06/01/2017 05:52 PM] (4) |
| Jun 1, 2017 | 52 | Amended Entry of appearance for Basil J. Lewris as principal counsel for Cross-Appellant Grunenthal GmbH. Service: 06/01/2017 by email. [435792] [Basil Lewris] [Entered: 06/01/2017 05:57 PM] (3) |
| Jun 1, 2017 | 53 | Amended Entry of appearance for Linda A. Wadler as of counsel for Cross-Appellant Grunenthal GmbH. Service: 06/01/2017 by email. [435793] [Basil Lewris] [Entered: 06/01/2017 05:59 PM] (3) |
| Jun 1, 2017 | 54 | Amended Entry of appearance for Krista E. Bianco as of counsel for Cross-Appellant Grunenthal GmbH. Service: 06/01/2017 by email. [435794] [Basil Lewris] [Entered: 06/01/2017 06:00 PM] (3) |
| Jun 1, 2017 | 55 | Amended Certificate of Interest for the Cross-Appellant Grunenthal GmbH. Service: 06/01/2017 by email. [435795] [Basil Lewris] [Entered: 06/01/2017 06:01 PM] (3) |
| May 25, 2017 | 33 | ORDER filed. Appeal No. 2017-1153 is reactivated and the above-captioned appeals are consolidated. The revised official caption is reflected in the order. The appellants’ opening briefs are due no later than 60 days from the date of filing of this order. The cross appellants’ opening and response brief is due no later than 40 days thereafter. The appellants’ response and reply brief and the appellees’ response brief are due no later than 40 days thereafter. The cross-appellants’ reply brief is due no later than 14 days thereafter. Service: 05/25/2017 by clerk. [434081] [17-1153, 17-2048, 17-2049, 17-2050] [LMS] [Entered: 05/25/2017 10:55 AM] (2) |
| May 17, 2017 | 32 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account of Mr. Michael Sitzman for Depomed, Inc. The e-mail address, (HHartman@gibsondunn.com), associated with your CM/ECF account has generated a delivery failure notice. Counsel should promptly report a change in contact information with the Pacer Service Center (see Fed. Cir. R. 47.3(c)(1). [432123] [PMM] [Entered: 05/17/2017 09:49 AM] (0) |
| May 16, 2017 | 31 | Entry of appearance for Ahmed M.T. Riaz as of counsel for Appellant Alkem Laboratories Limited. Service: 05/16/2017 by email. [431786] [Ahmed Riaz] [Entered: 05/16/2017 11:06 AM] (2) |
| May 15, 2017 | 30 | Letter from Appellees Depomed, Inc. and Grunenthal GmbH Regarding Notices of Appeal From Final Judgment. Service: 05/15/2017 by email. [431424] [Michael Sitzman] [Entered: 05/15/2017 02:26 PM] (2) |
| May 9, 2017 | 29 | RESPONSE of Appellant Alkem Laboratories Limited to the court order to set case manager tickler date [27] ,court order [27]. Service: 05/09/2017 by email. [430036] [Ahmed Riaz] [Entered: 05/09/2017 02:52 PM] (4) |
| Dec 19, 2016 | 28 | ORDER filed. The motions [24] [25] are denied as moot. Service: 12/19/2016 by clerk. [392370] [LMS] [Entered: 12/19/2016 04:07 PM] (2) |
| Dec 16, 2016 | 27 | ORDER filed. The motion to deactivate appeal [7] , to terminate appeal [7] is granted to the extent that the appeal is deactivated. Within 30 days from the date of entry of a Rule 58 judgment, the parties are directed to inform this court as to how they believe the appeal should proceed. Service: 12/16/2016 by clerk. [391669] [NL] [Entered: 12/16/2016 09:38 AM] (3) |
| Dec 14, 2016 | 24 | MOTION of Appellant Alkem Laboratories Limited to extend the time to 01/17/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: opposed]. Service: 12/14/2016 by email. [391102] [Imron Aly] [Entered: 12/14/2016 04:28 PM] (7) |
| Dec 14, 2016 | 25 | MOTION of Appellant Alkem Laboratories Limited suspension of briefing schedule until Fed. R. Civ. P. 58 judgment is entered. Any response is due within 10 days of service [Consent: opposed]. Service: 12/14/2016 by email. [391110] [Imron Aly] [Entered: 12/14/2016 04:56 PM] (12) |
| Nov 23, 2016 | 23 | Transcript Purchase Order Form for the Appellant Alkem Laboratories Limited indicating that a transcript is already on file. Service: 11/23/2016 by email. [385699] [Imron Aly] [Entered: 11/23/2016 08:54 AM] (2) |
| Nov 18, 2016 | 21 | RESPONSE of Appellant Alkem Laboratories Limited to the motion to terminate appeal [7] filed by Appellees Depomed, Inc. and Grunenthal GmbH in 17-1153 , motion to deactivate appeal [7] filed by Appellees Depomed, Inc. and Grunenthal GmbH in 17-1153. Service: 11/18/2016 by email. [384679] [Imron Aly] [Entered: 11/18/2016 03:49 PM] (6) |
| Nov 18, 2016 | 22 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: response Docket No. [21], ERROR: The response does not use the official case caption. CORRECTION: All future filings should use the official case caption found on the docket sheet. There is no need to refile the response. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [384693] [JCA] [Entered: 11/18/2016 04:08 PM] (0) |
| Nov 17, 2016 | 13 | Docketing Statement for the Appellee Grunenthal GmbH. Service: 11/17/2016 by email. [384073] [Basil Lewris] [Entered: 11/17/2016 11:15 AM] (4) |
| Nov 17, 2016 | 14 | Entry of appearance for Imron T. Aly as principal counsel for Appellant Alkem Laboratories Limited. Service: 11/17/2016 by email. [384147] [Imron Aly] [Entered: 11/17/2016 01:44 PM] (2) |
| Nov 17, 2016 | 15 | Certificate of Interest for the Appellant Alkem Laboratories Limited. Service: 11/17/2016 by email. [384150] [Imron Aly] [Entered: 11/17/2016 01:45 PM] (2) |
| Nov 17, 2016 | 16 | Docketing Statement for the Appellant Alkem Laboratories Limited. Service: 11/17/2016 by email. [384152] [Imron Aly] [Entered: 11/17/2016 01:47 PM] (4) |
| Nov 17, 2016 | 17 | Entry of appearance for Neil LLoyd as of counsel for Appellant Alkem Laboratories Limited. Service: 11/17/2016 by email. [384156] [Neil Lloyd] [Entered: 11/17/2016 01:52 PM] (2) |
| Nov 17, 2016 | 18 | Entry of appearance for Jason G. Harp as of counsel for Appellant Alkem Laboratories Limited. Service: 11/17/2016 by email. [384158] [Jason Harp] [Entered: 11/17/2016 01:55 PM] (2) |
| Nov 17, 2016 | 19 | Docketing Statement for the Appellee Depomed, Inc.. Service: 11/17/2016 by email. [384216] [Michael Sitzman] [Entered: 11/17/2016 03:29 PM] (5) |
| Nov 17, 2016 | 20 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: APPELLANT ALKEM LABORATORIES LIMITED's docketing statement Docket No. [16], certificate of interest Docket No. [15], attorney entries of appearance Docket Nos. [18], [17], [14], ERROR: the pdf documents submitted with these filings are not in text-searchable format. CORRECTION: No further action is required on these documents. In the future, all pdf's submitted for filing in the ECF system must be in text-searchable format. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [384248] [AT] [Entered: 11/17/2016 03:47 PM] (0) |
| Nov 9, 2016 | 8 | Entry of appearance for Basil J. Lewris as principal counsel for Appellee Grunenthal GmbH. Service: 11/09/2016 by email, US mail. [381616] [Basil Lewris] [Entered: 11/09/2016 12:00 PM] (2) |
| Nov 9, 2016 | 9 | Certificate of Interest for the Appellee Grunenthal GmbH. Service: 11/09/2016 by email, US mail. [381617] [Basil Lewris] [Entered: 11/09/2016 12:02 PM] (3) |
| Nov 9, 2016 | 10 | Entry of appearance for Linda A. Wadler as of counsel for Appellee Grunenthal GmbH. Service: 11/09/2016 by email, US mail. [381618] [Basil Lewris] [Entered: 11/09/2016 12:03 PM] (2) |
| Nov 9, 2016 | 11 | Entry of appearance for Krista E. Bianco as of counsel for Appellee Grunenthal GmbH. Service: 11/09/2016 by email, US mail. [381619] [Krista Bianco] [Entered: 11/09/2016 12:06 PM] (2) |
| Nov 9, 2016 | 12 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: APPELLEES' motion to dismiss or deactivate appeal Docket No. [7]. ERROR: the motion does not reflect the official caption issued by the clerk, does not include Grunenthal's certificate of interest; and exhibit A is not text searchable. CORRECTION: No further action is required on this document. The motion has been filed. Please note the filing requirements for future submissions. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [381635] [AT] [Entered: 11/09/2016 12:55 PM] (0) |
| Nov 8, 2016 | 2 | Entry of appearance for Michael A. Sitzman as principal counsel for Appellee Depomed, Inc.. Service: 11/08/2016 by email. [381462] [Michael Sitzman] [Entered: 11/08/2016 05:46 PM] (3) |
| Nov 8, 2016 | 3 | Entry of appearance for Timothy P. Best as of counsel for Appellee Depomed, Inc.. Service: 11/08/2016 by email. [381467] [Michael Sitzman] [Entered: 11/08/2016 05:48 PM] (3) |
| Nov 8, 2016 | 4 | Entry of appearance for Jaysen S. Chung as of counsel for Appellee Depomed, Inc.. Service: 11/08/2016 by email. [381470] [Michael Sitzman] [Entered: 11/08/2016 05:50 PM] (3) |
| Nov 8, 2016 | 5 | Entry of appearance for Christine L. Ranney as of counsel for Appellee Depomed, Inc.. Service: 11/08/2016 by email. [381472] [Michael Sitzman] [Entered: 11/08/2016 05:52 PM] (3) |
| Nov 8, 2016 | 6 | Certificate of Interest for the Appellee Depomed, Inc.. Service: 11/08/2016 by email. [381473] [Michael Sitzman] [Entered: 11/08/2016 05:54 PM] (2) |
| Nov 8, 2016 | 7 | MOTION of Appellees Depomed, Inc. and Grunenthal GmbH to terminate appeal through Dismissal., to deactivate appeal. Any response is due within 10 days of service [Consent: opposed]. Service: 11/08/2016 by email. [381474] [Michael Sitzman] [Entered: 11/08/2016 06:01 PM] (16) |
| Nov 3, 2016 | 1 | Appeal docketed. Received: 11/01/2016. [380081]Entry of Appearance due 11/17/2016. Certificate of Interest is due on 11/17/2016. Docketing Statement due 11/17/2016. Appellant's brief is due 01/03/2017. [AT] [Entered: 11/03/2016 12:55 PM] (248) |
